Skip to main content
OpenTrials
Completed

NCT Number: NCT07523230

Effect of Antiemetic Timing on Nausea Severity and Patient Comfort in the Emergency Department

Nausea is a common symptom among patients presenting to the emergency department and can negatively affect patient comfort and clinical outcomes. The timing of antiemetic administration may play a critical role in symptom control; however, evidence regarding the optimal timing remains limited. This multicenter interventional study aims to evaluate the effect of early versus delayed antiemetic administration on nausea severity and patient comfort in adult emergency department patients. Participants will be assigned to receive antiemetic treatment either within the first 30 minutes after triage or after 30 minutes. Nausea severity will be assessed using a numeric rating scale, and patient comfort will be evaluated at predefined time points. The findings of this study are expected to contribute to improving symptom management and optimizing clinical practices in emergency care settings.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul Medipol University Hospital, Emergency Department

Istanbul, 34810, Turkey (Türkiye)

About this study

Nausea is a frequently encountered symptom in emergency department (ED) patients and is associated with decreased patient comfort, prolonged ED stay, and reduced satisfaction with care. Timely management of nausea is essential for improving patient outcomes; however, there is limited evidence regarding the impact of antiemetic administration timing on symptom relief and patient comfort. This study is designed as a prospective, multicenter interventional study to evaluate the effect of antiemetic timing on nausea severity and patient comfort in adult ED patients.

Eligible participants will include adult patients presenting to the ED with nausea. Participants will be allocated into two groups based on the timing of antiemetic administration: early administration (within 30 minutes after triage) and delayed administration (after 30 minutes). Antiemetic agents will be administered according to standard clinical practice.

The primary outcome of the study is nausea severity, which will be measured using a validated numeric rating scale. Secondary outcomes include patient comfort levels and changes in nausea over time. Measurements will be obtained at baseline and at predefined time intervals following antiemetic administration.

This study aims to provide evidence on whether early administration of antiemetic therapy leads to improved symptom control and patient comfort compared to delayed administration. The results may inform clinical decision-making and contribute to the development of evidence-based protocols for nausea management in emergency settings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • Presentation to the emergency department with nausea (with or without vomiting)
  • Receiving antiemetic treatment
  • Ability to communicate
  • Ability to provide informed consent
  • Ability to undergo nausea assessment using a Numeric Rating Scale (NRS) at initial evaluation

Exclusion criteria

  • Altered level of consciousness (unconscious or confused)
  • Intubated patients
  • Severe psychiatric conditions (e.g., psychosis or delirium)
  • Patients in critical condition requiring immediate resuscitation
  • Hemodynamic instability
  • Inability to communicate (including language barrier or severe hearing/speech impairment preventing scale application)
  • Refusal to participate

Treatment and study plan

Antiemetic Timing

Behavioral

The intervention consists of adjusting the timing of routine antiemetic administration in emergency department patients without altering the type or dosage of medication. Participants are assigned to receive antiemetics either within 30 minutes (early group) or after 30 minutes (delayed group) following triage (T0), in accordance with standard clinical care. Outcome measures include nausea severity assessed using a Numeric Rating Scale (NRS, 0-10) at T0, Tpost30, and Tpost60, and comfort level assessed at T0 and Tpost60.

Primary outcomes

  1. Change in Nausea Severity

    Time frame: Baseline (T0), 30 minutes (Tpost30), and 60 minutes (Tpost60)

    Nausea severity will be assessed using a Numeric Rating Scale (NRS, 0-10). Measurements will be obtained at baseline (T0), 30 minutes (Tpost30), and 60 minutes (Tpost60). The primary outcome is the change in nausea severity over time between the early and delayed antiemetic groups.

Secondary outcomes

  1. Comfort Level

    Time frame: Baseline (T0) and 60 minutes (Tpost60)

    Comfort level will be assessed using the General Comfort Questionnaire-Short Form. Measurements will be obtained at baseline (T0) and 60 minutes (Tpost60). Differences between groups will be analyzed.

Sponsors and collaborators

Lead sponsor

muzeyyen ataseven

Other

Registry information

Official study title

The Effect of Antiemetic Timing on Nausea Severity and Patient Comfort in the Emergency Department: A Multicenter Interventional Study

Acronym: ANTI-ED

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 13, 2026
Registry last updated
Apr 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.